Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium).
To assess the utilisation of medical services and social (community) assistance in patients with multiple sclerosis of different disability and to calculate the direct healthcare costs to society.
Methods- (1) One hundred and eighty four patients with multiple sclerosis were classified into four grades of disability according to a simplified Kurzke disability status scale. (2) Patients were interviewed with a structured questionnaire containing questions on their sociodemographic status, the use of inpatient and outpatient medical services and pharmaceutical products during the previous year, the use of social assistance, and the purchase of prosthetics and charges for house adaptations during the previous five years. (3) Data were also prospectively collected by means of four week diary annotations of all medical and social acts and their duration.
After correction for the disability distribution the yearly costs for the 5500 patients with multiple sclerosis in Flanders was estimated to be ECU 13 106 000 for ambulatory care including rehabilitation and district nursing and ECU 3 234 000 for pharmaceutical products.
To these direct medical costs ECU 3 491 000 for social assistance and ECU 4 938 000 for prosthetics and adaptations should be added.
The yearly costs for admissions to hospital including permanent residence in an institution and pharmacy was ECU 26 581 000. (...)
Mots-clés Pascal : Sclérose en plaque, Incapacité, Belgique, Europe, Aide sociale, Services sociaux, Utilisation, Service santé, Analyse coût, Coût global, Economie santé, Homme, Système nerveux pathologie, Système nerveux central pathologie, Maladie inflammatoire
Mots-clés Pascal anglais : Multiple sclerosis, Disability, Belgium, Europe, Social help, Social assistance, Use, Health service, Cost analysis, Life cycle cost, Health economy, Human, Nervous system diseases, Central nervous system disease, Inflammatory disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0230226
Code Inist : 002B17F. Création : 11/09/1998.